Icosavax Stock Forecast, Price & News

Icosavax (NASDAQ:ICVX) Frequently Asked Questions

Is Icosavax a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Icosavax in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Icosavax stock.
View analyst ratings for Icosavax or view top-rated stocks.

What stocks does MarketBeat like better than Icosavax?

Wall Street analysts have given Icosavax a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Icosavax wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Icosavax?

Icosavax saw a increase in short interest in September. As of September 30th, there was short interest totaling 736,300 shares, an increase of 107.4% from the September 15th total of 355,000 shares. Based on an average daily trading volume, of 280,600 shares, the short-interest ratio is currently 2.6 days. Approximately 3.1% of the shares of the company are short sold.
View Icosavax's Short Interest.

When is Icosavax's next earnings date?

Icosavax is scheduled to release its next quarterly earnings announcement on Monday, December 13th 2021.
View our earnings forecast for Icosavax.

How were Icosavax's earnings last quarter?

Icosavax Inc (NASDAQ:ICVX) posted its quarterly earnings data on Monday, September, 13th. The company reported ($2.86) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.90) by $1.96. The business had revenue of $1.90 million for the quarter, compared to the consensus estimate of $3.10 million.
View Icosavax's earnings history.

What price target have analysts set for ICVX?

4 brokers have issued 12-month target prices for Icosavax's stock. Their forecasts range from $45.70 to $50.00. On average, they anticipate Icosavax's stock price to reach $48.57 in the next twelve months. This suggests a possible upside of 81.0% from the stock's current price.
View analysts' price targets for Icosavax or view top-rated stocks among Wall Street analysts.

Who are some of Icosavax's key competitors?

Some companies that are related to Icosavax include Iovance Biotherapeutics (IOVA), Sana Biotechnology (SANA), Ablynx (ABLYF), Adagio Therapeutics (ADGI), SpringWorks Therapeutics (SWTX), Recursion Pharmaceuticals (RXRX), Bavarian Nordic A/S (BVNRY), Ginkgo Bioworks (DNA), Soaring Eagle Acquisition (SRNG), Kymera Therapeutics (KYMR), Relay Therapeutics (RLAY), BioCryst Pharmaceuticals (BCRX), Editas Medicine (EDIT), Instil Bio (TIL) and Vericel (VCEL).
View all of ICVX's competitors.

When did Icosavax IPO?

(ICVX) raised $150 million in an IPO on Thursday, July 29th 2021. The company issued 10,000,000 shares at $14.00-$16.00 per share.

What is Icosavax's stock symbol?

Icosavax trades on the NASDAQ under the ticker symbol "ICVX."

When did the company's quiet period expire?

Icosavax's quiet period expired on Tuesday, September 7th. Icosavax had issued 12,133,333 shares in its initial public offering on July 29th. The total size of the offering was $181,999,995 based on an initial share price of $15.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Icosavax?

Shares of ICVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Icosavax's stock price today?

One share of ICVX stock can currently be purchased for approximately $26.83.

How much money does Icosavax make?

Icosavax has a market capitalization of $1.06 billion.

How many employees does Icosavax have?

Icosavax employs 2,021 workers across the globe.

What is Icosavax's official website?

The official website for Icosavax is icosavax.com.

How can I contact Icosavax?

The company can be reached via email at [email protected].